This symposium is dedicated to the memory of John L. Telford for his seminal contribution to the identification and characterisation of virulence factors of bacterial pathogens that led to the development of life-saving vaccines.

Organizers


Erica Telford
ANRS | Emerging Infectious Diseases, France


Francesco Frati
University of Siena, Italy


Rino Rappuoli
GSK Vaccines,
University of Siena, Italy


Philippe Sansonetti
Institut Pasteur, France


Cosima Baldari
University of Siena, Italy

  

Invited speakers

 


Gennaro Ciliberto
University of Catanzaro Magna Graecia & National Cancer Institute Regina Elena Rome, Italy

Isabel Delany
GSK Vaccines, Italy

Androulla Efstratiou
WHO Collaborating Centre for Diphtheria and Streptococcal Infections, UK Health Security Agency & Imperial College, London, UK

Christiane Gerke
Institut Pasteur, Paris, France

Dennis Kasper
Harvard Medical School, Boston, USA

Marie-Paule Kieny
Chair of the Governance Board of the Medicines Patent Pool

Mogens Kilian
Aarhus University, Denmark

Antonio Lanzavecchia, MD
National Institute of Molecular Genetics, INGM, Milan, Italy – Group Leader
Humabs BioMed, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland – SVP and Senior Research Fellow

Emanuele Montomoli
University of Siena & VisMederi srl Siena, Italy

Roger M. Perlmutter
Chairman and Chief Executive Officer, Eikon Therapeutics, Inc., Hayward, CA. USA

Maria Grazia Pizza
GSK Vaccines & GSK Vaccine Institute for Global Health, Siena, Italy

Rino Rappuoli
GSK Vaccines & University of Siena, Italy

Federica Sallusto
Institut for Research in Biomedicine, Bellinzona, Switzerland

Philippe Sansonetti
Institut Pasteur Paris & Collège de France, Paris, France

Hayato Urabe
Global Health Innovative Technology Fund, Tokyo, Japan

Nick Valiante
Glyde Bio Inc, Cambridge, USA